Bone Health in Hyperemesis Gravidarum

NCT02862496 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-08-11

No results posted yet for this study

Summary

The purpose of the study is to determine whether maternal bone resorption would be seen in Hyperemesis Gravidarum and could be detected in early period using serum vitamin D levels, serum calcium (Ca) levels, serum parathormone (PTH) levels and urine N- telopeptide levels in the patients with Hyperemesis Gravidarum.

Conditions

  • Hyperemesis Gravidarum

Sponsors & Collaborators

  • Kayseri Education and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Erdem SAHİN · Kayseri Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02862496 on ClinicalTrials.gov